FDA Inspection 969113 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on April 21, 2016 in New Hyde Park, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 21, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New Hyde Park, NY (United States)